chr3-20183961-T-C

Variant summary

Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PP5_Very_Strong

The NM_001199251.3(SGO1):​c.67A>G​(p.Lys23Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000164 in 1,612,714 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00017 ( 0 hom. )

Consequence

SGO1
NM_001199251.3 missense

Scores

6
9
3

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 6.24
Variant links:
Genes affected
SGO1 (HGNC:25088): (shugoshin 1) The protein encoded by this gene is a member of the shugoshin family of proteins. This protein is thought to protect centromeric cohesin from cleavage during mitotic prophase by preventing phosphorylation of a cohesin subunit. Reduced expression of this gene leads to the premature loss of centromeric cohesion, mis-segregation of sister chromatids, and mitotic arrest. Evidence suggests that this protein also protects a small subset of cohesin found along the length of the chromosome arms during mitotic prophase. An isoform lacking exon 6 has been shown to play a role in the cohesion of centrioles (PMID: 16582621 and PMID:18331714). Mutations in this gene have been associated with Chronic Atrial and Intestinal Dysrhythmia (CAID) syndrome, characterized by the co-occurrence of Sick Sinus Syndrome (SSS) and Chronic Intestinal Pseudo-obstruction (CIPO) within the first four decades of life (PMID:25282101). Fibroblast cells from CAID patients exhibited both increased cell proliferation and higher rates of senescence. Pseudogenes of this gene have been found on chromosomes 1 and 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2015]
SGO1-AS1 (HGNC:41081): (SGO1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 8 ACMG points.

PP5
Variant 3-20183961-T-C is Pathogenic according to our data. Variant chr3-20183961-T-C is described in ClinVar as [Pathogenic]. Clinvar id is 162627.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-20183961-T-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SGO1NM_001199251.3 linkc.67A>G p.Lys23Glu missense_variant Exon 2 of 8 ENST00000412997.6 NP_001186180.1 Q5FBB7-6B5BUA4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SGO1ENST00000412997.6 linkc.67A>G p.Lys23Glu missense_variant Exon 2 of 8 1 NM_001199251.3 ENSP00000410458.1 Q5FBB7-6

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
152234
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000188
AC:
47
AN:
250128
AF XY:
0.000192
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.000321
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000256
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000167
AC:
244
AN:
1460480
Hom.:
0
Cov.:
31
AF XY:
0.000154
AC XY:
112
AN XY:
726440
show subpopulations
Gnomad4 AFR exome
AF:
0.0000898
AC:
3
AN:
33414
Gnomad4 AMR exome
AF:
0.000225
AC:
10
AN:
44518
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
26112
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39610
Gnomad4 SAS exome
AF:
0.000233
AC:
20
AN:
85734
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
53312
Gnomad4 NFE exome
AF:
0.000183
AC:
203
AN:
1111664
Gnomad4 Remaining exome
AF:
0.0000828
AC:
5
AN:
60352
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
152234
Hom.:
0
Cov.:
33
AF XY:
0.000148
AC XY:
11
AN XY:
74370
show subpopulations
Gnomad4 AFR
AF:
0.0000482
AC:
0.0000482393
AN:
0.0000482393
Gnomad4 AMR
AF:
0.0000654
AC:
0.0000654022
AN:
0.0000654022
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.000250
AC:
0.000249919
AN:
0.000249919
Gnomad4 OTH
AF:
0.000478
AC:
0.000478011
AN:
0.000478011
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000204
Hom.:
0
Bravo
AF:
0.000162
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000181
AC:
22
EpiCase
AF:
0.000164
EpiControl
AF:
0.000296

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Chronic atrial and intestinal dysrhythmia Pathogenic:3
Nov 01, 2014
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

-
Neuberg Centre For Genomic Medicine, NCGM
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The missense c.67A>G p.Lys23Glu variant in SGO1 gene has been reported in homozygous state in multiple individuals affected with gastrointestinal disorder Chetaille et al., 2014. In vitro studies in patient fibroblasts with homozygous p.Lys23Glu suggest abnormal cell progression, cell signalling, epigenetic modifications, and protein expression compared to controls Chetaille et al., 2014. The variant is reported with allele frequency of 0.02% in gnomAD Exomes and is novel not in any individuals in 1000 Genomes. This variant has been reported to the ClinVar database as Pathogenic multiple submissions. The amino acid change p.Lys23Glu in SGO1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Lys at position 23 is changed to a Glu changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. -

Apr 12, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Pathogenic:1
Jan 11, 2023
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In vitro studies in patient fibroblasts with homozygous p.K23E suggest abnormal cell progression, cell signalling, epigenetic modifications, and protein expression compared to controls (Chetaille et al., 2014; Piche et al., 2019); This variant is associated with the following publications: (PMID: 31516082, 30739867, 25282101, 35799243, 32213217, 33953173) -

SGO1-related disorder Pathogenic:1
Jul 01, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The SGO1 c.67A>G variant is predicted to result in the amino acid substitution p.Lys23Glu. This missense change has been documented in the homozygous state in multiple unrelated individuals with chronic atrial and intestinal dysrhythmia, and functional studies support its pathogenicity (Chetaille et al 2014. PubMed ID: 25282101; Piché et al. 2019. PubMed ID: 30739867). This variant is reported in 0.031% of alleles in individuals of Latino descent in gnomAD. This variant is interpreted as likely pathogenic. -

Cardiovascular phenotype Pathogenic:1
May 09, 2024
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PS3, PS4, PP1_mod, PP3, PP5 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.67
BayesDel_addAF
Benign
-0.037
T
BayesDel_noAF
Uncertain
0.040
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.68
.;.;D;.;.;D;.;.;.;.;.
Eigen
Pathogenic
0.73
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.78
.;.;.;T;T;T;T;T;T;.;T
M_CAP
Uncertain
0.11
D
MetaRNN
Uncertain
0.70
D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
-0.21
T
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-2.9
D;D;D;D;D;D;D;D;D;D;D
REVEL
Pathogenic
0.77
Sift
Uncertain
0.0030
D;D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D;D;D;D;D;D;D;D
Polyphen
1.0
D;D;D;D;D;D;D;D;.;D;D
Vest4
0.70
MVP
0.84
MPC
0.19
ClinPred
0.21
T
GERP RS
5.7
Varity_R
0.76
gMVP
0.32
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199815268; hg19: chr3-20225453; API